eFFECTOR Therapeutics, Inc.
EFTR
$0.0002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.12% | -58.00% | -736.80% | -254.46% | -240.47% |
| Total Depreciation and Amortization | 46.05% | 109.43% | 248.39% | 426.32% | 245.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.31% | 174.87% | 114.11% | 110.22% | 107.93% |
| Change in Net Operating Assets | -79.56% | -37.06% | -88.75% | -36.10% | 354.89% |
| Cash from Operations | -7.96% | -14.10% | -27.51% | -24.72% | -2.47% |
| Capital Expenditure | 43.24% | 49.48% | 73.95% | 43.75% | -49.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.98% | 182.53% | 143.26% | 159.26% | 169.42% |
| Cash from Investing | -104.44% | 181.10% | 142.57% | 158.45% | 168.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10,986.38% | 637.00% | 424.96% | -73.26% | -99.42% |
| Repurchase of Common Stock | -- | -- | 42.19% | 42.19% | -259.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -100.00% | 100.00% |
| Cash from Financing | 14,347.95% | 667.92% | 442.70% | -73.29% | -99.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 170.68% | 115.04% | 84.80% | -129.95% | -926.29% |